Kirk Taylor Announces Postdoctoral Research Opportunity on Megakaryocyte and Platelet Communication at University of Reading
Kirk Taylor, Lecturer in Biomedical Sciences in the University of Reading, shared an insightful post on LinkedIn:
“Pleased to share that we are looking to recruit a postdoc to join the Reading Platelet Group.
This is an exciting project that will explore how megakaryocytes and platelets communicate using advanced microscopy and flow cytometry approaches.
The project will dissect and characterise intercellular communication pathways to build a model of how megakaryocytes and platelets interact. The experimental design will increase the complexity of interactions and the role of control mechanisms in 2D, 3D, and 4D. Using established in vivo approaches, the post holder will design and conduct assays to model thrombus formation under physiologically relevant conditions.
The postholder is expected to be a central link in the communication of staff involved in the project. In particular, this includes collaboration with a second PDRA employed by the project responsible for theoretical and computational developments. Strong communication skills and an ability to work in a multidisciplinary environment are hence essential.”
Apply here:
Stay updated with Hemostasis Today.
-
Sep 24, 2026, 13:41Mahmoud Samir Bayomi: Raise ITP Awareness and Improve Patient Care
-
Sep 24, 2026, 12:56Maria Helena Parrinello: A New Score for Chronic GvHD Risk Assessment at the SIE Congress
-
Sep 24, 2026, 12:44Shehab Mohamed: TP53 Mutations and Outcomes in Myeloproliferative Neoplasms
-
Sep 24, 2026, 12:34Francesca Palandri: Is There Still a Place for Splenectomy in ITP in the Modern Era?
-
Sep 24, 2026, 12:15Cedric Hermans: RPTH Illustrated Review on Von Willebrand Disease
-
Sep 24, 2026, 11:48Factor XII Inhibition and the Future of Contact Pathway Targeting
-
Sep 24, 2026, 08:55Andres Gudino: Clot Characterization Through Hounsfield Units in Ischemic Stroke
-
Sep 24, 2026, 06:52Gina Sado: Screening-Detected Atrial Fibrillation Carries High Risk of Heart Failure
-
Sep 24, 2026, 06:33Benjamin Vipler: Optimal Oral Anticoagulation Choice in Atrial Fibrillation and Advanced CKD